12/15/15 07:30 | 12/14/15 | PLX | Protalix Biotherapeutics, Inc. | FL | Health | BioPrd | Biological Products, (No Diag | Maimon Yossi | L3 | O | VP,CFO | P | 8 | 0.7800 | 1 | 10 | 5 | 195 | D | -80 | -63 | -60 | -44 | -24 | -24 | -24 | -11 | 1 | 29 | 9 | 15 | 1 | -62 |
5/4/12 17:13 | 5/2/12 | PLX | Protalix Biotherapeutics, Inc. | FL | Health | BioPrd | Biological Products, (No Diag | Maimon Yossi | L3 | O | VP,CFO | M.d | 206 | 1.64 | 11 | 126 | | 0 | I | 0 | 3 | 9 | 12 | 13 | 8 | -6 | -3 | 1 | 0 | -11 | -17 | -27 | -22 |
5/4/12 17:13 | 5/2/12 | PLX | Protalix Biotherapeutics, Inc. | FL | Health | BioPrd | Biological Products, (No Diag | Maimon Yossi | L3 | O | VP,CFO | S.d | -898 | 7.13 | 11 | -126 | -100 | 0 | I | 0 | 3 | 9 | 12 | 13 | 8 | -6 | -3 | 1 | 0 | -11 | -17 | -27 | -22 |
10/8/10 16:10 | 10/7/10 | PLX | Protalix Biotherapeutics, Inc. | FL | Health | BioPrd | Biological Products, (No Diag | Maimon Yossi | L3 | O | VP,CFO | S.d | -677 | 9.67 | 5 | -70 | -100 | 0 | I | 350 | 9 | 49 | 54 | 29 | 16 | 16 | 7 | -4 | -5 | 3 | 10 | -32 | -50 |
10/8/10 16:10 | 10/7/10 | PLX | Protalix Biotherapeutics, Inc. | FL | Health | BioPrd | Biological Products, (No Diag | Maimon Yossi | L3 | O | VP,CFO | M.d | 76 | 0.9720 | 5 | 78 | | 0 | I | 350 | 9 | 49 | 54 | 29 | 16 | 16 | 7 | -4 | -5 | 3 | 10 | -32 | -50 |
9/8/10 16:34 | 9/3/10 | PLX | Protalix Biotherapeutics, Inc. | FL | Health | BioPrd | Biological Products, (No Diag | Maimon Yossi | L3 | O | VP,CFO | S.dm | -565 | 8.07 | 3 | -70 | -100 | 0 | I | 267 | 11 | 15 | 27 | 24 | 13 | 8 | 7 | 0 | 5 | 16 | 8 | -23 | -44 |
9/8/10 16:34 | 9/7/10 | PLX | Protalix Biotherapeutics, Inc. | FL | Health | BioPrd | Biological Products, (No Diag | Maimon Yossi | L3 | O | VP,CFO | M.d | 68 | 0.9720 | 3 | 70 | | 0 | I | 267 | 11 | 15 | 27 | 24 | 13 | 8 | 7 | 0 | 5 | 16 | 8 | -23 | -44 |
10/19/09 20:42 | 10/15/09 | PLX | Protalix Biotherapeutics, Inc. | FL | Health | BioPrd | Biological Products, (No Diag | Maimon Yossi | L3 | O | VP,CFO | S.dm | -1,419 | 9.46 | 5 | -150 | -100 | 0 | I | -71 | 370 | 261 | 67 | 25 | 13 | 3 | 7 | -3 | -11 | 17 | -24 | -30 | 5 |
10/19/09 20:42 | 10/16/09 | PLX | Protalix Biotherapeutics, Inc. | FL | Health | BioPrd | Biological Products, (No Diag | Maimon Yossi | L3 | O | VP,CFO | M.d | 163 | 0.9720 | 5 | 168 | | 0 | I | -71 | 370 | 261 | 67 | 25 | 13 | 3 | 7 | -3 | -11 | 17 | -24 | -30 | 5 |
7/8/09 17:00 | 7/6/09 | PLX | Protalix Biotherapeutics, Inc. | FL | Health | BioPrd | Biological Products, (No Diag | Maimon Yossi | L3 | O | VP,CFO | S.dm | -255 | 5.11 | 2 | -50 | -100 | 0 | I | -83 | 87 | 162 | 109 | 35 | 24 | 19 | 5 | 2 | 8 | 42 | 69 | 48 | 30 |
7/8/09 17:00 | 7/7/09 | PLX | Protalix Biotherapeutics, Inc. | FL | Health | BioPrd | Biological Products, (No Diag | Maimon Yossi | L3 | O | VP,CFO | M.d | 60 | 0.9720 | 2 | 62 | | 0 | I | -83 | 87 | 162 | 109 | 35 | 24 | 19 | 5 | 2 | 8 | 42 | 69 | 48 | 30 |
5/19/09 19:01 | 5/18/09 | PLX | Protalix Biotherapeutics, Inc. | FL | Health | BioPrd | Biological Products, (No Diag | Maimon Yossi | L3 | O | VP,CFO | M.d | 39 | 0.9720 | 0 | 40 | | 0 | I | -86 | 33 | 146 | 46 | 60 | 40 | 16 | 8 | -2 | -6 | 7 | 66 | 180 | 69 |
5/19/09 19:01 | 5/18/09 | PLX | Protalix Biotherapeutics, Inc. | FL | Health | BioPrd | Biological Products, (No Diag | Maimon Yossi | L3 | O | VP,CFO | S.d | -120 | 4.00 | 0 | -30 | -100 | 0 | I | -86 | 33 | 146 | 46 | 60 | 40 | 16 | 8 | -2 | -6 | 7 | 66 | 180 | 69 |
3/13/09 19:18 | 3/11/09 | PLX | Protalix Biotherapeutics, Inc. | FL | Health | BioPrd | Biological Products, (No Diag | Maimon Yossi | L3 | O | VP,CFO | S.dm | -109 | 2.24 | 0 | -49 | -100 | 0 | I | -90 | -26 | -5 | 42 | -13 | -15 | 2 | -2 | 0 | 8 | 11 | 71 | 240 | 219 |
3/13/09 19:18 | 3/13/09 | PLX | Protalix Biotherapeutics, Inc. | FL | Health | BioPrd | Biological Products, (No Diag | Maimon Yossi | L3 | O | VP,CFO | M.d | 39 | 0.9720 | 0 | 40 | | 0 | I | -90 | -26 | -5 | 42 | -13 | -15 | 2 | -2 | 0 | 8 | 11 | 71 | 240 | 219 |
2/26/08 17:20 | 2/22/08 | PLX | Protalix Biotherapeutics, Inc. | FL | Health | BioPrd | Biological Products, (No Diag | Yossi Maimon | L3 | O | VP,CFO | M.d | 84 | 0.9720 | 0 | 86 | | 27 | I | -92 | -84 | -93 | -27 | 12 | -4 | 3 | -1 | 4 | -6 | -16 | -9 | -24 | -17 |
2/26/08 17:20 | 2/25/08 | PLX | Protalix Biotherapeutics, Inc. | FL | Health | BioPrd | Biological Products, (No Diag | Yossi Maimon | L3 | O | VP,CFO | S.d | -106 | 3.18 | 0 | -33 | -56 | 27 | I | -92 | -84 | -93 | -27 | 12 | -4 | 3 | -1 | 4 | -6 | -16 | -9 | -24 | -17 |